Different aspects of early and late development of atrial fibrillation during hospitalization in cryptogenic stroke.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 03 2021
Historique:
received: 18 12 2020
accepted: 17 03 2021
entrez: 30 3 2021
pubmed: 31 3 2021
medline: 27 10 2021
Statut: epublish

Résumé

The detection of underlying atrial fibrillation (AF) has become increasingly possible by insertable cardiac monitoring (ICM). During hospitalization for cryptogenic stroke, factors related to the early and late development of AF have not been studied. CHALLENGE ESUS/CS is a multicenter registry of cryptogenic stroke patients undergoing transesophageal echocardiography. Twelve-lead electrocardiogram, continuous cardiac monitoring, and 24-h Holter electrocardiogram were all used for the detection of AF. Early and late detection of AF was determined with an allocation ratio of 1:1 among patients with AF. A total of 677 patients (68.7 ± 12.8 years; 455 men) were enrolled, and 64 patients developed AF during hospitalization. Four days after admission was identified as the approximate median day to classify early and late phases to detect AF: ≤ 4 days, 37 patients; > 4 days, 27 patients. Multiple logistic regression analysis showed that spontaneous echo contrast (SEC) (OR 5.91; 95% CI 2.19-15.97; p < 0.001) was associated with AF ≤ 4 days, whereas a large infarction > 3 cm in diameter (OR 3.28; 95% CI 1.35-7.97; p = 0.009) was associated with AF > 4 days. SEC and large infarctions were important predictors of in-hospital AF detection, particularly in the early and late stages, respectively; thus, they could serve as indications for recommending ICM.

Identifiants

pubmed: 33782508
doi: 10.1038/s41598-021-86620-5
pii: 10.1038/s41598-021-86620-5
pmc: PMC8007744
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7127

Références

Ann Intern Med. 1998 Apr 15;128(8):639-47
pubmed: 9537937
N Engl J Med. 2019 May 16;380(20):1906-1917
pubmed: 31091372
Stroke. 2017 Apr;48(4):867-872
pubmed: 28265016
J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104626
pubmed: 31954605
N Engl J Med. 2014 Jun 26;370(26):2478-86
pubmed: 24963567
J Am Coll Cardiol. 1994 Mar 15;23(4):961-9
pubmed: 8106703
Atherosclerosis. 2015 Apr;239(2):476-82
pubmed: 25702618
J Am Heart Assoc. 2019 Aug 6;8(15):e012858
pubmed: 31364451
Eur J Neurol. 2020 Aug;27(8):1618-1624
pubmed: 32347993
N Engl J Med. 2014 Jun 26;370(26):2467-77
pubmed: 24963566
Angiology. 2020 Jul;71(6):559-566
pubmed: 32103687
J Interv Card Electrophysiol. 2004 Jun;10(3):221-6
pubmed: 15133358
J Am Coll Cardiol. 1998 Jun;31(7):1622-6
pubmed: 9626843
Neurology. 2013 Jul 30;81(5):444-7
pubmed: 23803318
Cerebrovasc Dis. 2020;49(2):144-150
pubmed: 32023609
Lancet Neurol. 2014 Apr;13(4):429-38
pubmed: 24646875
Atherosclerosis. 2019 May;284:181-186
pubmed: 30921601
Cerebrovasc Dis Extra. 2019;9(3):98-106
pubmed: 31542780
J Neurol. 2020 May;267(5):1482-1490
pubmed: 32016623
Ann Noninvasive Electrocardiol. 2020 Nov;25(6):e12785
pubmed: 32588512
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1370-6
pubmed: 23608370
Stroke. 2016 Nov;47(11):2714-2721
pubmed: 27703086
J Atheroscler Thromb. 2018 Jul 1;25(7):593-605
pubmed: 29199200
J Stroke. 2019 Sep;21(3):302-311
pubmed: 31590474
JAMA Neurol. 2019 Jul 1;76(7):764-773
pubmed: 30958508
Int J Cardiol. 2015 Apr 1;184:540-542
pubmed: 25767011
J Stroke Cerebrovasc Dis. 2017 Sep;26(9):1912-1915
pubmed: 28716584
N Engl J Med. 2018 Jun 07;378(23):2191-2201
pubmed: 29766772
Neurology. 2016 Sep 6;87(10):988-95
pubmed: 27488602
Stroke. 2012 Oct;43(10):2689-94
pubmed: 22871678

Auteurs

Ryosuke Doijiri (R)

Department of Neurology, Iwate Prefectural Central Hospital, Iwate, Japan.

Yuji Ueno (Y)

Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan. yuji-u@juntendo.ac.jp.

Muneaki Kikuno (M)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Department of Neurology, Tokyo Medical School, Tokyo, Japan.

Takahiro Shimizu (T)

Department of Neurology, St. Marianna University School of Medicine, Kanagawa, Japan.

Yohei Tateishi (Y)

Department of Neurology and Strokology, Nagasaki University Hospital, Nagasaki, Japan.

Ayako Kuriki (A)

Department of Neurology, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Hidehiro Takekawa (H)

Department of Neurology, Dokkyo Medical University, Tochigi, Japan.

Yoshiaki Shimada (Y)

Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.

Kodai Kanemaru (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Department of Neurology, Tokyo Medical School, Tokyo, Japan.

Yuki Kamiya (Y)

Department of Neurology, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Eriko Yamaguchi (E)

Department of Neurology, Iwate Prefectural Central Hospital, Iwate, Japan.

Masatoshi Koga (M)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.

Masafumi Ihara (M)

Department of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan.

Akira Tsujino (A)

Department of Neurology and Strokology, Nagasaki University Hospital, Nagasaki, Japan.

Koichi Hirata (K)

Department of Neurology, Dokkyo Medical University, Tochigi, Japan.

Yasuhiro Hasegawa (Y)

Department of Neurology, St. Marianna University School of Medicine, Kanagawa, Japan.

Takahiko Kikuchi (T)

Department of Neurology, Iwate Prefectural Central Hospital, Iwate, Japan.

Nobutaka Hattori (N)

Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.

Takao Urabe (T)

Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH